Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.53 |
| ▸ | AKT1 | P31749 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL566978 | 1.00 | NFE2L2 (0.61) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL566977 | 1.00 | NFE2L2 (0.61) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL23086309 | 0.90 | CES2 (0.57) | NFE2L2MEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL23086307 | 0.90 | CES2 (0.57) | NFE2L2MEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL17129921 | 0.88 | NFE2L2 (0.53) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL15080850 | 0.88 | NFE2L2 (0.53) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL17129920 | 0.86 | NFE2L2 (0.52) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL12720046 | 0.86 | MEN1 (0.47) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL566675 | 0.84 | NFE2L2 (0.64) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL566351 | 0.84 | DEGS1 (0.53) | NFE2L2MEN1KMT2AMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624214-B2 | Polymerizable absorbers of UV and high energy visible light | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4707342-A2 | CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | Johnson & Johnson Vision Care, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260044018-A1 | MULTIFOCAL CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | JOHNSON & JOHNSON VISION CARE (US) | 2026-02-12 | — | — | US | claimed |
| US-20260003209-A1 | TORIC CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | JOHNSON & JOHNSON VISION CARE (US) | 2026-01-01 | — | — | US | claimed |
| US-12486348-B2 | Contact lens displaying improved vision attributes | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-12-02 | — | — | US | claimed |
| US-20250362432-A1 | OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS | JOHNSON & JOHNSON VISION CARE (US) | 2025-11-27 | — | — | US | claimed |
| US-12481173-B2 | Multifocal contact lens displaying improved vision attributes | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2025-11-25 | — | — | US | claimed |
| EP-4022368-B1 | CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | JOHNSON & JOHNSON VISION CARE (US) | 2025-11-12 | — | — | EP | claimed |
| US-20250287942-A1 | FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-18 | — | — | US | claimed |
| EP-4540638-A1 | OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS | Johnson & Johnson Vision Care, Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| CN-101116012-B | Stabilized ultra-violet absorbers | ESSILOR INT | 2010-05-19 | — | — | CN | claimed |
| CN-101116012-A | Stabilized ultra-violet absorbers | ESSILOR INT (FR) | 2008-01-30 | — | — | CN | claimed |
| EP-1856562-A2 | STABILIZED ULTRA-VIOLET ABSORBERS | ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) | 2007-11-21 | — | — | EP | claimed |
| WO-2006084772-A2 | STABILIZED ULTRA-VIOLET ABSORBERS | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2006-08-17 | — | — | WO | claimed |
| US-20060175579-A1 | Stabilized ultra-violet absorbers | ESSILOR INTERNATIONAL (FR) | 2006-08-10 | — | — | US | claimed |
| CN-1124315-C | Ocular devices mfd. with free radical polymerizable latent ultra-violet absorbers | JOHNSON & JOHNSON VISIO PRODUC (US) | 2003-10-15 | — | — | CN | claimed |
| US-6566138-B1 | Fluorescent dye for use as diagnostic tool in monitor biological agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2003-05-20 | — | — | US | claimed |
| US-6218463-B1 | Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers | JOHNSON & JOHNSON VISION CARE, INC. | 2001-04-17 | — | — | US | claimed |
| CN-1233630-A | Ocular devices mfd. with free radical polymerizable latent ultra-violet absorbers | JOHNSON & JOHNSON VISIO PRODUC (US) | 1999-11-03 | — | — | CN | claimed |
| EP-0952467-A1 | Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers | JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) | 1999-10-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260044018-A1 | MULTIFOCAL CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | NECTIN4, CRYAB, PSEN1 | NFE2L2 251/4885MEN1 461/4885KMT2A 1647/4885 |
| US-20260003209-A1 | TORIC CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | TRPA1, LATS2, TEC | NFE2L2 509/4885MEN1 1810/4885KMT2A 2622/4885 |
| US-20250287942-A1 | FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS | ACHE, BCHE, DDT | NFE2L2 4207/4885MEN1 1220/4885KMT2A 2629/4885 |
| US-12624214-B2 | Polymerizable absorbers of UV and high energy visible light | CRY1, SCNN1G, MALT1 | NFE2L2 2941/4885MEN1 941/4885KMT2A 1560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.